Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111808106A discloses a novel acid-catalyzed route for pyrrolo[1,2-a]indoles. This method offers high yields, mild conditions, and significant cost reduction potential for supply chains.
Patent CN108239019A enables enzymatic synthesis of chiral piperidine esters. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110092735B reveals a high-yield Negishi coupling route for Eluxadoline intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical clients.
Novel patent CN120118017A details blue LED catalysis for 3-selenocyanoindoles. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112538033A details a Pd-catalyzed kinetic resolution method yielding high-purity chiral cyclophanes with superior enantioselectivity and scalability.
Patent CN113201015B reveals a zinc-catalyzed route for allyl organophosphorus compounds, offering cost-effective synthesis for pharma and agrochemical intermediates.
Patent CN105859800B details a high-yield synthesis of chiral ferrocene P,P ligands. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN106831603B reveals metal-free visible light synthesis for fluoropyrimidines, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113582865A details a novel copper-catalyzed route for alpha,alpha-disubstituted chiral amino acid esters, offering high enantioselectivity and streamlined manufacturing for API intermediates.
Novel enzymatic synthesis route for high-purity SOS1 inhibitor intermediate. Reduces steps, avoids hazardous reagents, ensures scalable supply chain reliability for global pharma partners.
Patent CN102382160B details a green capecitabine route using manganese chloride. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN119462581A reveals efficient one-pot synthesis for OLED intermediates reducing cost and waste significantly for global supply chains.
Patent CN116396189A details a novel B(C6F5)3 catalyzed route for high-purity (S)-(+)-1-indanyl isocyanate, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN103319526A analysis reveals a novel organocatalytic route for P-chiral phenol derivatives, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN102924362A reveals a green one-pot synthesis for Gliclazide intermediates using Gemini surfactants, offering significant cost reduction and supply chain reliability.
Patent CN111285769B details a polyionic liquid copper catalyst for efficient, green aqueous Henry reactions, offering high enantioselectivity and simplified supply chains for pharmaceutical intermediates.
Novel catalytic route for trifluoromethyl spiro oxindoles offering high stereoselectivity and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN113773227A details a visible-light mediated method for epsilon-cyano carboxylic acids using CO2. Offers cost-effective pharma intermediate manufacturing.
Patent CN102285896B details a novel chloramphenicol synthesis using benzaldehyde, offering high purity and reduced waste for reliable pharmaceutical intermediate supply chains.
Discover a novel preparation method for metal NHC complexes via patent CN101402644B, offering cost-effective catalytic solutions and scalable manufacturing for pharmaceutical intermediates.